The susceptibility of 135 Streptococcus suis strains isolated from pigs (n = 110) and from humans (n = 25) to 13 antimicrobial agents was studied by microdilution and disc diffusion methods using Mueller-Hinton Agar II (MH) supplemented with either defibrinated sheep blood (MHSB) or horse serum (MHHS). Results were similar for both methods used except for penicillin G whose zone diameters were reduced with MHSB compared with MHHS. When MH was supplemented with sheep blood, 39% of S. suis strains classified as penicillin susceptible by MHHS microdilution showed intermediate susceptibility. Nearly all strains were susceptible to penicillin G (except by disc diffusion in MHSB), amoxicillin, ceftiofur, florfenicol, gentamicin and bacitracin. The least active antimicrobial agents were doxycycline and macrolides/lincosamides. High-level resistance (MIC > 500 mg/L or zone diameters < 10 mm) to streptomycin and kanamycin was detected in only a few strains. The virulence of strains did not seem to be related to antimicrobial resistance because no statistical difference was reported between the proportion of resistant strains of S. suis isolated from pigs with meningitis, septicaemia and arthritis, and those from tonsils and nasal cavities. However, significant differences were found in the proportions of macrolide-or doxycycline-resistant strains between S. suis serotype 2 and other serotypes. The results of antibiotic susceptibility testing presented in this study indicate that β-lactams can be used in empirical treatment of human and pig S. suis infections in France.
Introduction
Streptococcus suis is an important swine pathogen causing meningitis, arthritis, septicaemia and endocarditis, but these bacteria can also be isolated from nasal cavities or tonsils of healthy pigs. 1, 2 Moreover, S. suis is a zoonotic agent and may cause meningitis in humans. 3 S. suis is divided into 35 serotypes, according to its polysaccharide capsular antigens. Virulence differs within the serotypes, serotype 2 being the serotype most often associated with disease. 1 Autogenous vaccines are used to protect swine against S. suis infections but since protection is incomplete, different types of vaccine are under investigation. 2 Among antimicrobial agents for treatment and prevention, the most active are the β-lactams, aminoglycosides, phenicols and fluoroquinolones. 4 Previous studies have investigated the antimicrobial susceptibility of clinical isolates but few have reported the susceptibility of S. suis strains isolated from healthy pigs. 5 Most reports of resistance concentrate on streptococci, notably Streptococcus pneumoniae. [6] [7] [8] [9] Shneerson et al. 10 described a case of human meningitis with a penicillin-resistant S. suis. β-Lactam-resistant S. suis strains have also been isolated from swine in Spain. 11 According to Gottschalk et al., 12 resistance has not been associated with the production of β-lactamase. More recently, resistance of S. suis to different antibiotics has been described. 1 We have undertaken a study to determine the antimicrobial susceptibility of 110 S. suis strains isolated in France from 1996 to 2000, from diseased as well as from healthy pigs, testing 13 antimicrobial agents by agar diffusion and microdilution methods. Twenty-five strains isolated from humans were also analysed.
Materials and methods
Antimicrobial susceptibility testing was carried out on all strains by disc diffusion and microdilution tests according to recommendations reported by the Comité de l'Antibiogramme de la Société Française de Microbiologie (CA-SFM). 13, 14 Bacterial strains Eighty-three S. suis strains collected from diseased pigs presenting with septicaemia, meningitis or arthritis, and 27 strains isolated from tonsils or nasal cavities of healthy pigs were tested in the study. Twenty-five S. suis strains isolated from humans from Canada (four strains), England (one strain), France (seven strains), the Netherlands (11 strains) and Mexico (two strains) were also included. Among these human strains, 24 were associated with pyrexia, meningitis, endocarditis or spondylitis, and one was isolated from a healthy human. 15 Identification and serotyping of S. suis were performed as described by Gottschalk et al. 16 The following reference strains were used for each batch of antimicrobial testing by both methods: Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.
Antimicrobial susceptibility testing
Disc diffusion method (DDM). The culture medium was Mueller-Hinton (MH) agar supplemented with 5% defibrinated sheep blood [MHSB (AES, Combourg, France) as recommended by the CA-SFM for streptococci 14 but also by the NCCLS 17 ] or with 5% horse serum [MHHS (LifeTechnologies, Cergy-Pontoise, France)].
The antimicrobial agents used in this study were: β-lactams: penicillin G (6 µg), amoxicillin (25 µg), ceftiofur (30 µg); aminoglycosides: streptomycin (500 µg), kanamycin (1000 µg), gentamicin (500 µg); polypeptides: bacitracin (10 IU); tetracyclines: doxycycline (30 IU); macrolides/ lincosamides: erythromycin (15 IU), spiramycin (100 µg), lincomycin (15 µg) (Bio-Rad, Marnes la Coquette, France), tylosin (30 µg) (Lilly-France, Saint-Cloud, France); phenicols: florfenicol (30 µg) (Schering-Plough, Segré, France). The method used was in accordance with CA-SFM recommendations. 13, 14 Briefly, three or four colonies from an overnight culture on Columbia agar supplemented with 5% sheep blood (AES) were suspended in MH broth (Becton Dickinson, Pont de Claix, France). The suspension was adjusted to a 0.5 McFarland standard and diluted to obtain an inoculum of 10 6 cfu/mL S. suis. For each strain two plates were inoculated by flooding MH agar (4 mm depth) supplemented with either 5% defibrinated sheep blood or 5% horse serum.
The antibiotic discs were placed with a disc dispenser (BioRad) and plates were incubated at 37°C in 5% CO 2 for 18 h. The zone diameters of S. suis strains and the reference strains were measured on the same day using a sliding caliper.
Microdilution method (MDM).
Susceptibility to antimicrobial agents was also determined by the MDM with MH broth supplemented with 5% horse serum using the following antimicrobial agents: penicillin G (0. The antimicrobial solutions were prepared as described in the 2000-2001 report of the CA-SFM, 14 and each dilution was distributed in 96-well microtitration plates (Merck Eurolab, Strasbourg, France). Bacterial suspensions were prepared as described for the DDM and adjusted to 5 × 10 5 cfu/mL. The microtitration plates were incubated at 37°C in 5% CO 2 for 18 h. The MIC was defined as the lowest concentration of antibiotic that inhibited development of visible growth.
Interpretation of susceptibility testing results
A strain was considered susceptible if the zone diameter was greater than or equal to the diameter breakpoint for the DDM or if the MIC was smaller than or equal to the MIC breakpoint for the MDM. The antibiotic breakpoints were taken from the CA-SFM 13,14 and the NCCLS 17 reports except for florfenicol, for which the breakpoints used were those given by the manufacturer. The distributions of resistant (R), intermediate (I) or susceptible (S) strains were compared according to the three methods used and the agreement of these classifications was analysed for each strain. If a discord was detected, it was defined as 'major' if a strain was classified 'S' to an antimicrobial agent with one method and 'R' with the other method. The discord was defined as 'minor' if a strain was classified 'I' to an antimicrobial agent with one method and 'S' or 'R' with the other method.
Statistical analysis
For each antimicrobial agent, the effects of capsular type and origin of S. suis on the antimicrobial susceptibility were analysed with Fisher's exact test. This test was also used for the evaluation of the medium effect (MHSB or MHHS) on the antimicrobial susceptibility determined by the DDM. In all cases, differences were considered significant when P was <0.05.
Results
The distribution of S. suis isolates according to serotype is presented in Tables 1 and 2 . Sixty of the 110 strains (54.5%) isolated from pigs belonged to serotype 2. Most of them were associated with clinical signs and pathology: 55% with septicaemia, 50% with meningitis and 100% with arthritis. However, 44% of strains from healthy pigs were serotype 2. In humans, 96% of serotype 2 strains were associated with meningitis.
The four reference strains presented zone diameters and MICs similar to those reported by the CA-SFM (Tables 3  and 4) .
Good agreement was obtained for results by the DDM using MHSB and MHHS media for all antimicrobial agents except for penicillin G. For this molecule, the population of S. suis strains was divided by the larger diameter breakpoint into two sub-populations with MHSB, whereas all but one strain were classified as susceptible with MHHS ( Figure 1) . Moreover, for the two reference strains susceptible to penicillin G (S. aureus ATCC 25923 and E. faecalis 29212), zone diameters were slightly smaller with MHHS than with MHSB. The other two reference strains were 'R' to penicillin G and their zone diameters were identical with both media.
According to 'S', 'I' or 'R' classification of strains, significant differences (P < 0.05) were noted between the DDM and the MDM for streptomycin and bacitracin. For streptomycin, only four strains were classified as 'R' by DDM, and seven were classified as 'R' and five as 'I' by the MDM. For bacitracin, only one strain was classified as 'R' by the DDM, whereas nine strains were 'R' by the MDM (Tables 1 and 2 ). Minor discords were reported mainly for penicillin G. Fiftythree strains were classified as 'I' by the DDM with MHSB ( Figure 1a ) and as 'S' by the DDM with MHHS (Figure 1b) and by the MDM (Table 2) . One strain was classified as 'I' by the DDM (Figure 1b ) and 'S' by the MDM (Table 2 ). Minor differences were also observed for macrolides/lincosamides, streptomycin, kanamycin and doxycycline. For these last molecules two to 10 strains were classified differently by the DDM or MDM, and one to four strains were classified differently by diffusion in MHSB or MHHS. The numbers of susceptible S. suis strains according to the DDM and MDM are reported in Tables 1 and 2, respectively. A large proportion of S. suis strains was classified as 'R' to doxycycline (79% with the DDM and MDM).
Resistance to macrolides and lincosamides was also widespread: for erythromycin, spiramycin, tylosin and lincomycin, only about 30% of the strains were classified as 'S' (Tables 1 and 2 ). Most of the strains were classified as 'S' to streptomycin and kanamycin. All strains were classified as 'S' to penicillin G (except by the DDM with MHSB), amoxicillin, ceftiofur, gentamicin and florfenicol. Most strains were also 'S' to bacitracin (99% with the DDM and 93% with the MDM).
No correlation (P ≥ 0.14) could be found between the proportions of 'S' S. suis isolated from diseased pigs (n = 83), healthy pigs (n = 27) or humans (n = 25). However, S. suis strains isolated from humans were significantly more frequently 'S' (P < 0.02) to erythromycin, spiramycin, tylosin, lincomycin and doxycycline than strains isolated from diseased pigs (meningitis, arthritis or septicaemia) or healthy pigs. The S. suis capsular type 2 strains (n = 85) were also significantly more frequently 'S' than other serotypes (n = 50) to erythromycin, spiramycin, tylosin and lincomycin (45-46% versus 8%, P < 0.0001) and doxycycline (31% versus 4%, P < 0.0001).
Discussion
This study was undertaken in order to propose a standardized method for testing the antimicrobial sensitivity of S. suis. As the DDM is very commonly used in France, it was decided to evaluate this technique, using either MHSB or MHHS, and to compare it with the broth dilution test, which seems more usual in many other countries.
The use of horse serum instead of sheep blood in the DDM seemed justified because the opacity of the medium due to supplementation with blood hinders precise measuring of zone diameters without opening the plates, a manipulation that might be dangerous with a zoonotic agent such as S. suis. Moreover, a large quantity of a single batch of horse serum can be stored at -20°C for periods up to 1 year, whereas sheep blood must be ordered regularly (several times a month), a feature that results in the use of many different batches of this component, which may influence the reproducibility of the test over time.
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quinupristin: the presence of blood in the base medium (IsoSensitest agar) also resulted in reduced zone diameters for Staphylococcus cohni, Staphylococcus capitis, Staphylococcus warneri, Enterococcus gallinarum and for the reference strains used in their study (S. aureus NCTC 6571, S. aureus ATCC 25923 and E. faecalis ATCC 29212). Although the distribution of the strains for penicillin G susceptibility appeared monomodal whatever the medium used, when using MHSB the CA-SFM-recommended breakpoint (29 mm) cut the population into two categories (60% susceptible and 40% intermediate), whereas all but one strain appeared susceptible when the test was performed with MHHS. As reported by Acar & Goldstein, 19 from an epidemiological point of view, the breakpoint should fit within the limits of clusters of microbial organisms with comparable susceptibility.
Thus, in our opinion, it would be judicious to advise laboratories to use horse serum in preferance to sheep blood as a supplement in MH for S. suis susceptibility testing by the DDM.
All S. suis strains were found to be 'S' to penicillin G (except by the DDM: 40% of strains were 'I' with MHSB and only one strain was 'I' with MHHS), amoxicillin, ceftiofur, florfenicol and gentamicin, and nearly all strains were 'S' to bacitracin. These results are in accordance with many other studies that have described S. suis as mainly susceptible to these antimicrobial agents. [20] [21] [22] [23] [24] The efficacy of β-lactams and gentamicin indicates that these antibiotics can still be chosen empirically when S. suis pig infection is detected in France. Moreover, in human meningitis the usual antimicrobial treatment (β-lactams) should be effective. However, S. suis resistance to β-lactams has been reported, 11, 12, 25 and streptococcal resistance to β-lactams has been described largely for S. pneumoniae. [6] [7] [8] 26, 27 Resistance to macrolides/lincosamides and tetracyclines described in this study has also been described in the literature to varying degrees in different countries. In France, Morvan 28 reported that 19% of 400 S. suis strains were susceptible to spiramycin, 38% to lincomycin and 18% to tetracycline. In Spain, Reams et al. 25 reported that 33%, 32% and 19% of S. suis strains were susceptible to erythromycin, clindamycin and tetracycline, respectively. In Denmark, 20% of S. suis strains, isolated from 1995 to 1997, were resistant to erythromycin, spiramycin, tylosin and lincomycin and 44% to tetracycline. These high rates of resistance to macrolides/ lincosamides and to tetracyclines might be explained by intensive use of tylosin (growth promoter) and tetracycline (therapeutic) in Danish pig production between 1992 and 1997. 29 Our study showed a high level of resistance to streptomycin and to kanamycin and confirmed the results published by other authors who also described this kind of resistance in varying degrees. 21, 24, 29, 30 The differences observed between countries might be explained by different usage of antimicrobial agents but could also be due to methodological differences between studies. Standardization of susceptibility testing methods at an international level would facilitate comparisons.
In our study, serotype 2 was found to be resistant to macrolides/lincosamides less frequently than other serotypes, in agreement with results reported by Aarestrup et al. 23 However, these results are inconsistent with those reported previously by Cantin et al. 31 No explanation can be found for this difference.
The difference between serotype susceptibility shown in our study could be explained by the fact that serotype 2 is considered to be the serotype most commonly associated with disease, 1 and most commonly isolated from healthy animals. Austin et al. 32 demonstrated that levels of colonization by antibiotic-resistant bacteria are related to antibiotic exposure and prevalence of bacteria. For a proportion of subjects treated, the proportion of resistance decreased when the prevalence of bacteria increased. This difference in resistance in relation to serotype may explain the difference in macrolide/ lincosamide and doxycycline susceptibility observed between human and pig strains, because all human strains tested belonged to serotype 2.
In conclusion, this study showed the efficacy of β-lactams against French isolates of S. suis. However, reduced susceptibility or resistance to penicillin G in S. suis has been reported in other countries. 11, 12, 21, 24 Therefore, it seems very important to monitor susceptibility of S. suis to penicillins, still the treatment of choice for human or pig S. suis infections. In France, the evolution of antibiotic susceptibility of S. suis will be surveyed using a novel epidemiological network, 'RESAP-ATH', which has been running since the beginning of the year 2001. The aim of this network is to collect results of susceptibility testing carried out by regional veterinary laboratories and thus to follow the evolution of resistance in common pathogenic bacteria from cattle, pigs and poultry. These laboratories routinely use the disc diffusion method described in this article and about 70% of them use sheep blood. Mechanisms of resistance detected by this network will be studied in our laboratory or in collaboration with other French research centres.
